HuGE Literature Finder
Records
1
-
30
| Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine. Frontiers in oncology 2023 2 12 1053035. De Paolis Elisa, Paris Ida, Tilocca Bruno, Roncada Paola, Foca Laura, Tiberi Giordana, D'Angelo Tatiana, Pavese Francesco, Muratore Margherita, Carbognin Luisa, Garganese Giorgia, Masetti Riccardo, Di Leone Alba, Fabi Alessandra, Scambia Giovanni, Urbani Andrea, Generali Daniele, Minucci Angelo, Santonocito Concet |
| Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. Cancers 2023 3 15 (5): . Gaba Faiza, Blyuss Oleg, Tan Alex, Munblit Daniel, Oxley Samuel, Khan Khalid, Legood Rosa, Manchanda Ranj |
| Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 1 JCO2201239. Yadav Siddhartha, Boddicker Nicholas J, Na Jie, Polley Eric C, Hu Chunling, Hart Steven N, Gnanaolivu Rohan D, Larson Nicole, Holtegaard Susan, Huang Huaizhi, Dunn Carolyn A, Teras Lauren R, Patel Alpa V, Lacey James V, Neuhausen Susan L, Martinez Elena, Haiman Christopher, Chen Fei, Ruddy Kathryn J, Olson Janet E, John Esther M, Kurian Allison W, Sandler Dale P, O'Brien Katie M, Taylor Jack A, Weinberg Clarice R, Anton-Culver Hoda, Ziogas Argyrios, Zirpoli Gary, Goldgar David E, Palmer Julie R, Domchek Susan M, Weitzel Jeffrey N, Nathanson Katherine L, Kraft Peter, Couch Fergus |
| Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers. Breast cancer research and treatment 2022 Aug . Nemati Shafaee Maryam, Goutsouliak Kristina, Lin Heather, Bevers Therese B, Gutierrez-Barrera Angelica, Bondy Melissa, Arun Ba |
| LRP1B mutation associates with increased tumor mutation burden and inferior prognosis in liver hepatocellular carcinoma. Medicine 2022 Jul 101 (26): e29763. Yu Ge, Mu Han, Fang Feng, Zhou Hongyuan, Li Huikai, Wu Qiang, Xiong Qingqing, Cui Yunlo |
| Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer Registry. Journal of pharmacy and pharmacology research 2022 10 6 (3): 147-157. Behring Michael, Bajpai Prachi, Afaq Farrukh, Elkholy Amr, Kim Hyung-Gyoon, Al Diffalha Sameer, Shrestha Sadeep, Manne Upend |
| Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nature communications 2022 11 13 (1): 6728. Shah Jennifer B, Pueschl Dana, Wubbenhorst Bradley, Fan Mengyao, Pluta John, D'Andrea Kurt, Hubert Anna P, Shilan Jake S, Zhou Wenting, Kraya Adam A, Llop Guevara Alba, Ruan Catherine, Serra Violeta, Balmaña Judith, Feldman Michael, Morin Pat J, Nayak Anupma, Maxwell Kara N, Domchek Susan M, Nathanson Katherine |
| Comparison between talazoparib and conventional chemotherapy in the treatment of HER2-positive breast cancer patients: A retrospective study. Frontiers in immunology 2022 13 901636. Wang Ning, Yu Xiaope |
| Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma. Frontiers in immunology 2022 7 13 925618. Zhang Zhen, Zeng Xiangyang, Wu Yinghua, Liu Yang, Zhang Xi, Song Zew |
| DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapy. The Prostate 2022 1 82 (4): 464-474. Zhu Shimiao, Zhang Zheng, Zhang Hui, Liu Zihao, Liu Min, Liu Qing, Zang Li, Wang Lili, Ji Junpeng, Wu Bo, Sun Libin, Zhang Zhenting, Cao Heran, Wang Yong, Wang Haitao, Shang Zhiqun, Niu Yuanj |
| Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Annals of oncology : official journal of the European Society for Medical Oncology 2022 6 33 (10): 1021-1028. Frenel J S, Kim J W, Aryal N, Asher R, Berton D, Vidal L, Pautier P, Ledermann J A, Penson R T, Oza A M, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon T W, Tamura K, Sonke G S, Freimund A E, Lee C K, Pujade-Lauraine |
| Expression Of Bap1 In Clear Cell Renal Cell Carcinoma. Journal of Ayub Medical College, Abbottabad : JAMC 2022 5 34 (2): 283-287. Fatima Arooj, Mushtaq Sajid, Loya Asif, Hassan Usman, Sheikh Umer Nis |
| Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer. NPJ breast cancer 2022 4 8 (1): 46. Garber Haven R, Raghavendra Akshara Singareeka, Lehner Michael, Qiao Wei, Gutierrez-Barrera Angelica M, Tripathy Debu, Arun Banu, Ibrahim Nuhad |
| Molecular profiles and circulating tumor-DNA detected in Chinese early stage breast cancer. Gland surgery 2022 3 11 (2): 319-329. Lan Jing, Zhou Ye-Hui, Zhang Min-Xia, Chen Dong-Qin, Wu Meng-Yao, Yu Zheng-Yu |
| Mutations in exon 11 (11.1 and 11.2) of the BRCA1 gene and risk factors for breast cancer in Burkina Faso. Journal of public health in Africa 2022 6 13 (1): 1921. Kiendrebeogo Isabelle Touwendpoulimdé, Zoure Abdou Azaque, Zongo Fabienne Ingrid, Ouattara Abdoul Karim, Ouedraogo Marie N L, Amegnona Jospin, Yonli Albert Théophane, Bayala Bagora, Zongo Nayi, Bambara Aboubacar Hierrhum, Sawadogo Alexis Yobi, Zohoncon Theodora M, Obiri-Yeboah Dorcas, Simpore Jacqu |
| Pan-cancer prognostic genetic mutations and clinicopathological factors associated with survival outcomes: a systematic review. NPJ precision oncology 2022 4 6 (1): 27. Kaubryte Jurgita, Lai Alvina |
| Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
| PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers. JCO precision oncology 2022 6 6 e2100531. Sokol Ethan S, Jin Dexter X, Fine Alexander, Trabucco Sally E, Maund Sophia, Frampton Garrett, Molinero Luciana, Antonarakis Emmanuel |
| Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience. Frontiers in genetics 2022 4 13 834265. Van der Merwe Nerina C, Combrink Herkulaas MvE, Ntaita Kholiwe S, Oosthuizen Ja |
| Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. Journal of Cancer 2022 1 13 (1): 88-101. Yan Yu-Chuan, Meng Guang-Xiao, Ding Zi-Niu, Liu Yan-Feng, Chen Zhi-Qiang, Yan Lun-Jie, Yang Ya-Fei, Liu Hui, Yang Chun-Cheng, Dong Zhao-Ru, Hong Jian-Guo, Li T |
| Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel. Experimental and molecular pathology 2022 9 128 104833. Salvati Annamaria, Carnevali Ileana, Alexandrova Elena, Facchi Sofia, Ronchi Susanna, Libera Laura, Sahnane Nora, Memoli Domenico, Lamberti Jessica, Amabile Sonia, Pepe Stefano, Tarallo Roberta, Sessa Fausto, Weisz Alessandro, Tibiletti Maria Grazia, Rizzo Frances |
| Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation. International journal of radiation oncology, biology, physics 2021 Oct . Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
| Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases. The oncologist 2021 Jun . Huang Richard S P, Haberberger James, McGregor Kimberly, Mata Douglas A, Decker Brennan, Hiemenz Matthew C, Lechpammer Mirna, Danziger Natalie, Schiavone Kelsie, Creeden James, Graf Ryon P, Strowd Roy, Lesser Glenn J, Razis Evangelia D, Bartsch Rupert, Giannoudis Athina, Bhogal Talvinder, Lin Nancy U, Pusztai Lajos, Ross Jeffrey S, Palmieri Carlo, Ramkissoon Shakti |
| Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer. Oncology 2021 Jun 1-8. Paik Hyun-June, Jung Youn Joo, Kim Dong Il, Lee Seungju, Jung Chang Shin, Kang Seok Kyung, Kim Jae-Joon, Oh So Yeon, Joo Ji Hyeon, Kim Hyun Y |
| Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. International journal of radiation oncology, biology, physics 2021 9 112 (2): 437-444. Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
| Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. The Prostate 2021 9 81 (16): 1382-1389. Sokolova Alexandra O, Marshall Catherine H, Lozano Rebeca, Gulati Roman, Ledet Elisa M, De Sarkar Navonil, Grivas Petros, Higano Celestia S, Montgomery Bruce, Nelson Peter S, Olmos David, Sokolov Vadim, Schweizer Michael T, Yezefski Todd A, Yu Evan Y, Paller Channing J, Sartor Oliver, Castro Elena, Antonarakis Emmanuel S, Cheng Heather |
| Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. JNCI cancer spectrum 2021 7 5 (2): . Kim Jung, Gianferante Matthew, Karyadi Danielle M, Hartley Stephen W, Frone Megan N, Luo Wen, Robison Leslie L, Armstrong Gregory T, Bhatia Smita, Dean Michael, Yeager Meredith, Zhu Bin, Song Lei, Sampson Joshua N, Yasui Yutaka, Leisenring Wendy M, Brodie Seth A, de Andrade Kelvin C, Fortes Fernanda P, Goldstein Alisa M, Khincha Payal P, Machiela Mitchell J, McMaster Mary L, Nickerson Michael L, Oba Leatrisse, Pemov Alexander, Pinheiro Maisa, Rotunno Melissa, Santiago Karina, Wegman-Ostrosky Talia, Diver W Ryan, Teras Lauren, Freedman Neal D, Hicks Belynda D, Zhu Bin, Wang Mingyi, Jones Kristine, Hutchinson Amy A, Dagnall Casey, Savage Sharon A, Tucker Margaret A, Chanock Stephen J, Morton Lindsay M, Stewart Douglas R, Mirabello Li |
| Multiple Mutation Detection for Risk Assessment in Patients with Breast Cancer by Using Next-Generation Sequencing. Annals of clinical and laboratory science 2021 10 51 (5): 670-677. Liu Peng-Fei, Zhuo Zhong-Ling, Xie Fei, Xian Hai-Peng, Liu Chang, Wang Shu, Zhao Xiao-T |
| Prognostic Impact of BRCA1 and BRCA2 Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients. Biology 2021 7 10 (7): . AbdelHamid Sherihan, El-Mesallamy Hala, Aziz Hany Abdel, Zekri Abdel-Rahm |
| Rucaparib in patients presenting a metastatic breast cancer with homologous recombination deficiency, without germline BRCA1/2 mutation. European journal of cancer (Oxford, England : 1990) 2021 11 159 283-295. Patsouris Anne, Diop Kadija, Tredan Olivier, Nenciu Daniel, Gonçalves Anthony, Arnedos Monica, Sablin Marie-Paule, Jézéquel Pascal, Jimenez Marta, Droin Nathalie, Bièche Ivan, Callens Céline, Loehr Andrea, Vicier Cécile, Guerin Catherine, Filleron Thomas, André Fabri |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: